Skip to menu Skip to content Skip to footer

1999

Conference Publication

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model

Saxton, N., Barclay, J., Clouston, A. D. and Fawcett, J. (1999). The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model. Transplantation Society of Australia/New Zealand Annual Scientific Meeting, Canberra, 14-16 Jun, 1999. Asia: Blackwell Science.

The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co..

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis

Nakazawa, Y., Walker, N. I., Kerlin, P., Strong, R. W., Lynch, S. V. and Clouston, A. D. (1999). Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis. As above, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Carlton, Vic.: Blackwell Science Asia.

Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis

1999

Conference Publication

High grade dysplasia in Barrett's oesophagus

Sanders, G., Smithers, B. M., Gotley, D. C. and Clouston, A. (1999). High grade dysplasia in Barrett's oesophagus. ArrayAustralian Gastroenterology Week 1999, Brisbane Convention Cen., 4-8 Oct, 1999. Carlton, Vic.: Blackwell Science, Asia.

High grade dysplasia in Barrett's oesophagus

1999

Conference Publication

Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver

Higgins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver. American Association for the Study of Liver Diseases, Dallas, USA, 5-9 Nov, 1999. Baltimore: Williams & Wilkins.

Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver

1999

Conference Publication

Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients

Higgins, C. M., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane Convention Centre, 4-8 October, 1999. Carlton South, Vic.: Blackwell Publishing Asia.

Clinicopathological analysis of hepatocellular carcinoma occuring in non-cirrhotic patients

1999

Conference Publication

The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients

Higgins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane, 4-8 Oct, 1999. Carlton, Vic: Blackwell Science.

The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients

1999

Conference Publication

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia.

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

1998

Conference Publication

Spur cell anemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.

Pascoe, A, Kerlin, P, Steadman, C, Clouston, A, Powell, L, Jazwinska, E, Lynch, S and Strong, R (1998). Spur cell anemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.. PHILADELPHIA: W B SAUNDERS CO. doi: 10.1016/S0016-5085(98)85357-2

Spur cell anemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.

1998

Conference Publication

Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells

Jonsson, J. R., Edwards-Smith, C. J., Hogan, P. G., Morotomi, Y., Clouston, A. D., Lynch, S. V., Strong, R. W. and Powell, E. E. (1998). Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons.

Human liver-derived leucocytes express FasL and immunomodulatory cytokines and induce apoptosis of activated allogeneic T cells

1997

Conference Publication

The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver

Ramm, G.A., Ooi, L. L. P. J., Gotley, D. C., Clouston, A. D., Bridle, K. R. and Crawford, D. H. G. (1997). The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver. 8th International Symposium on the Cells of the Hepatic Sinusoid, Bordeaux, France, 1-5 September 1996. Leiden, Netherlands: Kupffer Cell Foundation.

The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver

1997

Conference Publication

Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes

Jonsson, J. R., EdwardsSmith, C. J., Morotomi, Y., Hogan, P. G., Clouston, A. D., Lynch, S. V., Strong, R. W. and Powell, E. E. (1997). Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

Expression of Fas/FasL and bcl-2 in normal human liver derived leucocytes